Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

NCT02240888 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

RA
SLE
Vasculitis
Scleroderma
Sjögrens
Syndrome

Interventions

BIOLOGICAL: 0,5 mg Prevenar i.m.
BIOLOGICAL: 0,5 mg seasonal influenza vaccine i.m.

Sponsor

Region Skane